Myocardial ischemia-reperfusion in rats: Reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin

Journal of Pineal Research

Volumn 33, Issue 4, 2002, Pages 234-238

  Sahna, Engin ^a,b   Acet, Ahmet ^a   Kaya Ozer, M ^a   Olmez, Ercument ^a  

^a INONU UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Infarct size; Melatonin; Myocardialischemia reperfusion; Pinealectomy

Indexed keywords

MELATONIN;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; HEART INFARCTION SIZE; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; LEFT CORONARY ARTERY; MALE; NONHUMAN; PINEAL BODY; PINEALECTOMY; RAT;

ANIMALS; ANTIOXIDANTS; FREE RADICAL SCAVENGERS; MALE; MELATONIN; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PINEAL GLAND; RATS; RATS, WISTAR;

EID: 0036829769     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2002.02924.x     Document Type: Article

References (30)

1. Dhalla NS, Elmoselhi AB, Hata T et al. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000; 47:446-456.
2. Maxwell SR, Lip GY. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1997; 58:95-117.
3. Reiter RJ, Guerrero JM, Garcia JJ et al. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin. Ann NY Acad Sci 1998; 854:410-424.
4. Reiter RJ, Tan DX, Manchester LC et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. Cell Biochem Biophys 2001; 34:237-256.
5. Reiter RJ, Tan DX, Acuna-Castroviejo D et al. Melatonin: mechanisms and actions as an antioxidant. Curr Top Biophys 2000; 24:171-183.
6. Reiter RJ, Burkhardt S, Cabrera J et al. Beneficial neurobiological effects of melatonin under conditions of increased oxidative stress. Curr Med Chem 2002; 2:45-58.
7. Karbownik M, Reiter RJ. Melatonin protects against oxidative stress caused by delta-aminolevulinic acid: Implications for cancer reduction, Cancer Invest 2002; 20:276-286.
8. Vanecek J. Melatonin inhibits increase of intracellular calcium and cyclic AMP in neonatal rat pituitary via independent pathways. Mol Cell Endocrinol 1995; 107:149-153.
9. Tan DX, Manchester LC, Reiter RJ et al. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: Prevention by melatonin. J Pineal Res 1998; 25:184-191.
10. Kaneko S, Okumura K, Numaguchi Y et al. Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sci 2000; 67:101-112.
11. Lagneux C, Joyeux M, Demenge P et al. Protective effects of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci 2000; 66:503-509.
12. Sahna E, Olmez E, Acet A. Effects of physiological and pharmacological concentrations of melatonin on ischemia-reperfusion arrhythmias in rats: can the incidence of sudden cardiac death be reduced? J Pineal Res 2002; 32:194-198.
13. Kuszak J, Rodin M. A new technique of pinealectomy for adult rats. Experientia 1977; 33:283-284.
14. Liu YH, Yang XP, Sharov VG et al. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 1996; 27:7-13.
15. , Tsuchida A, Liu GS, Mullane K et al. Acadesine lowers temporal threshold for the myocardial infarct size limiting effect of preconditioning. Cardiovasc Res 1993; 27:116-120.
16. Grace MS, Cahill GM, Besharse JC. Melatonin deacetylation: Retinal vertebrate class distribution and Xenopus laevis tissue distribution. Brain Res 1991; 559:56-63.
17. Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev 1998; 78:687-721.
18. Zanoboni A, Forni A, Zanoboni-Muciaccia W et al. Effect of pinealectomy on arterial blood pressure and food and water intake in the rat. J Endocrinol Invest 1978; 1:125-130.
19. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med 2000; 109:315-323.
20. Cuzzocrea S, Riley DP, Caputi AP et al. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53:135-159.
21. Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol 2001; 426:1-10.
22. Chen LD, Tan DX, Reiter RJ et al. In vivo and in vitro effects of the pineal gland and melatonin on [Ca(2+) + Mg2+]-dependent ATPase in cardiac sarcolemma. J Pineal Res 1993; 14:178-183.
23. , Marktl W, Brugger P, Herold M. Melatonin and coronary heart disease. Wien Klin Wochenschr 1997; 109:747-749.
24. K-Laelamme A, Wu L, Foucart S et al. Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens 1998; 11:219-229.
25. Shida CS, Castrucci AM, Lamy-Freund MT. High melatonin solubility in aqueous medium. J Pineal Res 1994; 16:198-201.
26. Costa EJ, Shida CS, Biaggi MH et al. How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies. FEBS Lett 1997; 416:103-106.
27. Reiter RJ, Tan DX, Qi W et al. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Signals Recept 2000; 9:160-171.
28. Kilic E, Ozdemir YG, Bolay H et al. Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J Cereb Blood Flow Metab 1999; 19:511-516.
29. Dave RH, Hale SL, Kloner RA. The effect of melatonin on hemodynamics, blood flow, and myocardial infarct size in a rabbit model of ischemia-reperfusion. J Cardiovasc Pharmacol Ther 1998; 3:153-160.
30. Reiter RJ. The aging pineal gland and its physiological consequences. BioEssays 1992; 14:169-175.